Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.
By adding radiotherapy to the standard hormone treatment against prostate cancer, the 10 to 15 year survival rate for men with prostate cancer more than doubled, according to a long term follow-up study where Dr. Sophie Fosså is lead author. She is a professor at Oslo University Hospital in Norway.
Behind the study are Dr. Fosså and researchers from The Scandinavian Prostate Cancer Group.
"When this study started in 1996, the standard treatment was hormone therapy alone, but this trial continues to show that adding radiotherapy substantially boosts long-term survival," says Dr. Fosså.
"This combination more than doubles the 10-year survival rate and confirms that this approach should be a standard option for men with this type of prostate cancer who are expected to live at least another 10 years."
In all, 875 male patients from Norway, Sweden and Denmark participated in the study. Of these, 653 participants were Norwegians.
The figures presented by Dr. Fosså at the ASCO conference are a follow-up to an earlier study published in The Lancet in 2009 where Fosså and her colleagues demonstrate how radiotherapy in combination with hormone treatment reduced prostate cancer mortality from 24 to 12 percent.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Prostate / Prostate Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Oslo University Hospital. "Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study." Medical News Today. MediLexicon, Intl., 31 Jan. 2014. Web.
11 Mar. 2014. <http://www.medicalnewstoday.com/releases/271945>
Oslo University Hospital. (2014, January 31). "Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/271945.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.